IRESSA™ (Gefitinib) in Breast Cancer Patients
Clinical trial NCT00632723 · COMPLETED
Trial details
- NCT number
- NCT00632723
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.